baber/WOPTO huggingface dataset:
Patent JP-2000514276-A (JP)
Title: 段階的データ伝送および処理によるターボ符号化
IPC: H04L1/18
Filed: 1998-04-15
Abstract: (57)【要約】
通信システムにおけるターボ符号化は、情報を複数の段で符号化／復号して、パケットに誤りが生じたときにＬビットのパケット全体の再送信を防止する。ターボ符号化方式を使用して符号化器によって作成される１組の符号ビットに加えて、パンクチャリングされた１組の符号ビットが作成されて送信器のメモリに記憶される。元の１組の符号ビットがＬビット・データ・パケットとして通信路を介して受信器に送信され、受信器は元の１組の符号ビットに対応する受信したデータ・サンプルを記憶する。受信器はターボ復号器を使用してデータ・パケットを復号して、誤りのあるデータ・パケットを受信したかどうか判定する。もしそうなら、受信したデータ・サンプルがメモリに保持され、更なる情報の要求がなされる。そこで、パンクチャリングされた情報の幾分か又は全てが送信器から通信路を介して受信器へ転送される。第２段のターボ復号により、新しいデータ・サンプルが、記憶されている受信した元のデータ・サンプルと組み合わされる。この点で復号が正しくなる可能性が高いが、付加的な段の復号を使用し得る。
Patent JP-2001518861-A (JP)
Title: 弱安定境界を用いる衛星の軌道面向きの変更
IPC: G05D1/10
Filed: 1998-04-24
Abstract: (57)【要約】
本システムは、軌道を有する衛星の軌道面向きを変更する燃料効率のよい方法を提供する。この方法は直接的に行うのではなく、最初に衛星を月へＢＣＴ（弾道捕捉移転）で導くよう軌道制御する。月で衛星はファジー境界すなわち弱安定境界に存在する。ここで無視し得るほどの軌道制御が逆向きのＢＣＴをたどり衛星を地球に所望の軌道面向きで戻させる。もう一度軌道制御することで衛星を地球の新しい楕円軌道に乗せる。高度７００ｋｍ、軌道面向き３４°の円軌道にＬＥＯに向けて打ち上げられている衛星では軌道面向きを９０°に変更するのに約６ｋｍ／ｓを要するとなる。本方法は、ΔＶで測定されたときエネルギの意味ある節約と予期しない利益を達成する。飛行時間は、先の方法の１７０日から８８日あるいは６日まで実質的に短縮される。
Patent JP-2001524240-A (JP)
IPC: G06K17/00
Filed: 1998-04-30
Abstract: In order to render a chip card gratuity counter (6) more flexible, the invention consists in recording in the chip card memory (5) a file architecture to facilitate the management of its counters. Said architecture is characterised in that a counter unit file (7), wherein are located the counters relative to an application, is associated with rules (12) which are applicable thereto. Thus, the simple designation of a counter unit implies the implementation or rules applicable to the counters of this counter unit. This implementation is internal to the chip card and does not require any exchange with the reader. The chip card memory further comprises the rules file (12), the conditions file (13) and the computing file (14) the interaction of which provides greater flexibility of use.
Patent JP-2002505654-A (JP)
Title: 生物工学的試料または化学的試料を自動的に保管する装置
IPC: B65G1/04
Filed: 1999-04-20
Abstract: (57)【要約】
本発明の保管装置は、１つのハウジング（２２）から他のハウジングへ移動可能な導入導出装置（１９）を備え、該導入導出装置（１９）は、導入または導出すべき物体を移送するためのプラットフォーム（１７）を備え、該プラットフォームを１つのレベルから他のレベルヘ移動させるための手段（１８）が設けられている。また、互いに平行な２つの旋回アーム（３２）を有し、導入または導出すべき物体を把持するための挟み装置を備え、各アームは、２つのアーム（３２）に共通の水平軸を中心として回転する自由端を有する。さらに、上記水平軸を中心として上記アームを回転駆動するための手段（３３）と、上記アーム（３２）の各自由端の間隔を拡げたり狭めたりするための手段とを備えている。上記アーム（３２）の自由端には、上記アーム（３２）が軸（５４）を中心として回転駆動されるとき上記プラットフォーム（１７）の上を移動するための手段（３７、３８）が設けられ、上記アーム（３２）を回転駆動する手段（３３）および上記軸は、上記プラットフォーム（１７）に連結された鉛直軸（３１）に沿って移動自在であり、重力効果および水平軸を中心としたアーム（３２）の回転駆動効果によりこの鉛直軸に沿って移動する。
Patent MX-155310-A (MX)
Inventor: GRUENBERG ELLIOT
IPC: H04J3/16
Filed: 1982-05-25
Abstract: A digital multiplexer accommodates a large number of information signal channels per digital transmission channel through use of an improved statistical coding technique and successive frame transmission. The information signals are encoded into transmission code words, the code words are ordered into successive transmission frames and the transmission frames are sent over a communications highway to a remote location. An executive conferencing arrangement is also provided which utilizes a difference signal technique to set up a conferencing arrangement wherein each communications channel carrying analog information is connected to each communications channel not carrying analog information.
Patent NZ-207048-A (NZ)
Title: Vinylidene chloride copolymer aqueous latex composition;contact adhesive
Inventor: PADGET J C
IPC: C08L27/08
Filed: 1984-02-07
Abstract: Aqueous latex composition for use as a contact adhesive comprising a mixture of an amorphous copolymer A and an amorphous copolymer B where A comprises units of vinylidene chloride, an internally plasticizing comonomer like 2-ethylhexyl acrylate or n-butyl acrylate, optionally vinyl chloride and optionally a copolymerizable acid, and has Tg in the range -50 DEG  to <0 DEG  C., and B comprises units of vinylidene chloride, an alkyl acrylate and/or methacrylate or certain other comonomers, optionally vinyl chloride, and optionally a copolymerizable acid, and has a Tg in the range 0 DEG to 30 DEG  C.
Patent NZ-222110-A (NZ)
Title: Therapeutic powder form of spray-dried acetaminophen which includes ethyl cellulose and colloidal silica, and solid pharmaceutical dosage forms comprising the powder
Inventor: REUTER G L
IPC: A61K9/68
Filed: 1987-10-09
Abstract: A therapeutic taste-neutral powder form of acetaminophen is obtained by spray-drying a suspension of colloidal silica in a lower alkanol solution of acetaminophen and ethyl cellulose. The powder can be formulated into fast dissolving dosage forms, chewable tablets and the like.
Patent NZ-224636-A (NZ)
Title: Soluble aromatic polyimides
Inventor: HAYES R A
IPC: C08G73/10
Filed: 1988-05-16
Abstract: Highly soluble, optically transparent aromatic polyimides of the following formula are disclosed: <CHEM> where -X and -X1 are independently primary or secondary alkyl groups having 1 to 5 carbon atoms,  -X is different than -X1,  -Y is independently -H, or -Z,  -Z is independently -Cl, -Br or -I,  r = 0-100% of r+t, and  s = 100% t = 100% -r of r+t are disclosed. f
Patent NZ-225728-A (NZ)
Title: 4'-deshydroxyepipodophyllotoxin glucosides, precursors, and medicaments
Inventor: SAULNIER MARK GEORGE
IPC: C07H17/04
Filed: 1988-08-08
Abstract: Novel 4 min -deshydroxyepipodophyllotoxin glucosides are provided as antitumor agents useful in inhibiting the growth of mammalian tumors. The invention also provides novel intermediates and processes for the preparation of the 4 min -deshydroxyepipodophyllotoxin glucoside end-products. A preferred embodiment is 4 min -deshydroxyetoposide.
Patent NZ-232743-A (NZ)
Title: Processing of soya beans to form textured soya protein in the form of discrete chunks by steam treating an acidified aqueous dispersion of comminuted soya beans
Inventor: MCCABE EDWARD M
IPC: A23L11/30
Filed: 1990-03-01
Abstract: A method of processing whole soybeans to produce discrete, irregularly-shaped chunks or pieces of textured proteinaceous material which are free from off-flavors and odors and have a meat-like texture and appearance. Whole soybeans are hydrated and acidified to a pH in the range of about 4.5 to 6.5 and the pH of the soybeans is maintained in this range throughout processing. The acidified whole soybeans are ground in an aqueous medium to provide an aqueous slurry or dough of soybean particles having a pH in the range of 4.5-6.5. The aqueous acidic slurry or dough is passed through a confined treatment zone in which high temperature pressurized steam is injected directly into a confined stream of the slurry or dough under conditions which effect texturization of the soy protein in the form of discrete chunks or pieces which are discharged from the treatment zone. The texturized pieces, when discharged from the treatment zone or when dried and rehydrated are free of off-flavors and odors and have a meat-like texture, firmness and appearance. They are suitable for use in a wide variety of food products, including frozen products, canned products and dry mix products. If desired, additives such as flavoring, coloring, fat, seasoning and other proteinaceous materials may be incorporated in the texturized soy protein pieces.
Patent NZ-234367-A (NZ)
Title: Forming macrocomposite bodies by self generated vacuum techniques and products so formed
Inventor: KANTNER ROBERT CAMPBELL
IPC: B22D19/00
Filed: 1990-07-04
Abstract: The present invention relates to a novel process for forming macrocomposite bodies. Particularly, a suitable matrix metal (33), typically in a molten state, is in contact with a suitable mass of filler material or preform (31) located adjacent to, or in contact with, at least one second material in the presence of a suitable reactive atmosphere in an impermeable container (32), at least at some point during the process, which permits a reaction to occur between the reactive atmosphere and the molten matrix metal (33) and/or mass of filler material or preform (31) and/or impermeable container (32), thereby causing molten matrix metal (33) to infiltrate the mass of filler material or preform (31) due to, at least in part, the creation of a self-generated vacuum. Such self-generated vacuum infiltration occurs without the application of any external pressure or vacuum. The molten matrix metal (33) infiltrates the mass of filler material or preform (31) to such an extent that the molten matrix metal (33) contacts at least a portion of the at least one second material. Upon cooling the matrix metal (33) to a temperature below the melting point of the matrix metal, a macrocomposite body is formed comprising a metal matrix composite body bonded to at least a portion of the at least one second material.
Patent NZ-265642-A (NZ)
Title: Cosmetic product; topical lipidic composition, details regarding fatty acid components of triglycerides present
Inventor: BRACCO UMBERTO
IPC: A61K8/00
Filed: 1994-04-26
Abstract: Lipid composition for cosmetic products based on a mixture of oils which are chosen so as to maintain a balance between all the classes of lipids capable of affording the essential fatty acids in optimum physiological proportions and of regulating the metabolism of these fatty acids with physiological responses which are desired for the skin. This composition is particularly suitable for aqueous cosmetic compositions such as, for example, creams or milks or anhyrous compositions for care of the body.
Patent NZ-270811-A (NZ)
Title: Self-adhesive transdermal matrix system comprising a poly(styrene-isoprene-styrene)triblock copolymer and a hormone
Inventor: MIKLER CLAUDE
IPC: A61K47/32
Filed: 1995-03-27
Abstract: Self-adhesive transdermal matrix material for percutaneous admin. of hormones comprises (1) a support and (2) a self-adhesive matrix comprising (by wt.): (a) 20-42 pts. triblock poly(styrene-isoprene-styrene) (SIS) copolymer; (b) 35-55 pts. tackifying resin (TR); (c) 5-25 pts. plasticiser, i.e. oleyl alcohol, peglicol-5-oleate, propyleneglycol laurate (PGL) or polypropoxylated cetyl alcohol; (d) 5-15 pts. crotamiton and/or an N-substd. 2-pyrrolidone deriv. (I); (e) 0.01-1 pt. stabiliser and (f) 0.1-5 pts. oestrogenic and/or progestational hormones.
Patent NZ-277802-A (NZ)
Title: Vaccines comprising an antigenic component, qs21, 3-de-o-acylated monophosphoryl lipid a (3d-mpl) and a metabolisable oil in water emulsion, and tocopherol or tween 80
Inventor: MOMIN PATRICIA MARIE
IPC: A61K47/44
Filed: 1994-12-20
Abstract: The present invention provides vaccine compositions comprising an oil in water emulsion optionally with 3 De-O-acylated monophosphoryl lipid A and QS21. The vaccines compositions are potent inducers of a range of immune responses.
Patent NZ-295725-A (NZ)
Title: Hydroxamic acid and carboxylic acid derivatives, preparation and use thereof
Inventor: BECKETT RAYMOND PAUL
IPC: A61K31/381
Filed: 1995-11-27
Abstract: PCT No. PCT/GB95/02770 Sec. 371 Date May 21, 1997 Sec. 102(e) Date May 21, 1997 PCT Filed Nov. 27, 1995 PCT Pub. No. WO96/16931 PCT Pub. Date Jun. 6, 1996Compounds of general formula (I), principally characterized in that R4 is a polyether group, are water soluble matrix metalloproteinase inhibitors.    <IMAGE>  (I)
Patent NZ-301917-A (NZ)
Title: Mutants of Rb and p53 genes and use for the regulation of cell growth and treatment of cancerous and non-cancerous proliferative diseases
Inventor: FUNG YUEN KAI
IPC: C07H21/04
Filed: 1995-12-22
Abstract: An isolated synthetic mutated Rb gene encoding a mutated functionally active retinoblastoma protein.  The Rb gene is mutated by changing nucleotides that encode for amino acids in conserved homology regions P1, P3 and P5.  Also disclosed is the use of the Rb gene for the treatment of pathological cell proliferative diseases, wherein the treatment comprises administration to a non-cancerous or cancerous proliferating cell of the DNA molecule.
Patent NZ-303951-A (NZ)
Title: Use of penciclovir and famciclovire for treating human herpesvirus 8
Inventor: ESSER KLAUS MAX
IPC: A61P/
Filed: 1996-03-05
Abstract: The present invention is directed to the use of a compound of Formula (A),or a bioprecursor, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of either of the foregoing in the manufacture of a medicament for use in the treatment, including prophylaxis of HHV-8 infection.
Patent NZ-305540-A (NZ)
Title: Distribution of electronic money with receipt issuance
Inventor: ROSEN SHOLOM S
IPC: G06Q40/02
Filed: 1996-03-11
Abstract: A system for the open distribution of electronic money is provided having a customer trusted agent associated with a first money module, a merchant trusted agent that establishes a first cryptographically secure session with the customer trusted agent and associated with a second money module. Where the money modules establish a second cryptographically secure session. The customer trusted agent provides electronic money purchase or sale information and an account credential to the merchant trusted agent, and the merchant trusted agent provides a receipt ticket to the customer trusted agent. The merchant trusted agent accesses an authorization network and initiates an authorization process using information from the electronic money purchase or sale information and the account credential. Upon receiving authorization, the merchant trusted agent initiates a transfer of electronic money from the second money module to the first money module in the case of a purchase, or initiates a transfer of electronic money from the first money module to the second money module in the case of a sale.
Patent NZ-309131-A (NZ)
Title: Dispersion compensation in optical fibre transmission
Inventor: LAMING RICHARD IAN
IPC: H04B10/2519
Filed: 1997-02-21
Abstract: An optical transmission apparatus for transmission of optical signals at an optical wavelength of about 1550 nanometers. The optical transmission apparatus includes a single mode optical fiber link formed of optical fiber having substantially zero dispersion at an optical wavelength of about 1300 nanometers and a dispersion of about 17 picoseconds per nanometer-kilometer at an optical wavelength of about 1500 nanometers. Further, at least one dispersion compensating chirped optical fiber grating is coupled to the optical fiber link, the aggregate dispersion of the at least one dispersion compensating chirped optical fiber grating substantially compensating for the dispersion of the optical fiber link. Further, the at least one dispersion compensating chirped optical fiber grating is coupled at respective positions substantially symmetrically disposed about the longitudinal center of the optical fiber link.
Patent NZ-331862-A (NZ)
Title: Compositions and methods for selectively cross-linking films and improved film articles resulting therefrom
Inventor: BABROWICZ ROBERT
IPC: C08F279/00
Filed: 1997-03-25
Abstract: The application relates to polymeric compositions capable of providing enhanced cross-linking efficiency, to single and multilayer films having the subject composition contained within at least one layer of film.  To a method of treating film to provide enhanced cross-link within at least one layer of the film; and to the resultant cross-linked film product.  Also included are articles made from the cross-linked film product.
Patent NZ-337058-A (NZ)
Title: Composition for cleaning hard surfaces, comprising a synergistic blend of a surface tension reducing agent, a superwetting agent and an organic coupling and/or degreasing agent
Inventor: BLACK ROBERT H
IPC: C23G1/06
Filed: 1998-12-10
Abstract: An aqueous hard surface cleaner composition, comprising: about 0.02 to 0.2% by weight of a surface tension reducing agent; about 0.01 to 0. 1% by weight of a superwetting agent; and about 0.75 to 3% by weight of an organic agent selected from the group consisting of a coupling agent, a degreasing agent, and mixtures thereof; wherein the pH of the aqueous composition is in a range of about 4 to 9. As shown in the figure, the three interfaces synergistically acted upon by the aqueous cleaner composition are the cleaner/air interface (10) (between the air (40) and the aqueous cleaner composition (20) when applied to the soil deposit (80) on solid substrate (50)), the cleaner/substrate interface (60), and the cleaner/soil interface (70) (with the soil/substrate interface being (30)).
Patent NZ-500694-A (NZ)
Title: Use of chimeric mutational vector (CMV), a macromolecule and a ligand for cell surface receptor adhesion molecule (clatherin) in gene therapy; the CMV vector derived from REC2 homologous pairing with Ustilago maydis
Inventor: STEER CLIFFORD J
IPC: A61K48/00
Filed: 1998-04-30
Abstract: A composition comprising (a) a recombinagenic oligonucleobase; (b) an aqueous carrier; and (c) a macromolecular carrier, which comprises a ligand for a clathrin-coated pit receptor, wherein the macromolecular carrier is selected from the group consisting of (i) an aqueous-cored lipid vesicle, wherein the aqueous core contains the oligonucleotides; (ii) a lipid nanosphere, which comprises a lipophilic salt of the oligonucleobase, and (iii) a polycation having an average molecular weight of between 500 daltons and 1.3 Md wherein the polycation forms a salt with the oligonucleotide. The composition is suitable for inducing specific genetic changes in endogenous genes of the cells of an animal. The genetic changes are effected by oligonucleotides or oligonucleotide derivatives and analogs, which are generally less than about 100 nucleotides in length. In one embodiment the ligand is lactose or galactose and the genetic changes are made in hepatocytes. Repair of mutant genes having a Crigler-Najjar like phenotype and Hemophilia B phenotype were observed.
Patent NZ-501369-A (NZ)
Title: Bottle, to be secured to a filling head, comprising a plunger contained in a valve body
Inventor: DUCHON BRENT
IPC: B01F35/60
Filed: 1997-01-17
Abstract: A bottle 22 adapted to be secured to a filling head 20 comprises a valve body 92 with a longitudinal axis.  The valve body includes a vent port 104 and a first channel with a distal end.  A plunger 124 is contained within the valve body.  Plunger 124 defines a second channel and a fluid port 106 communicates with the second channel.  Plunger 124 has a first position wherein vent port 104 and fluid port 106 are closed and a second position wherein vent port 104 and fluid port 106 are open with fluid port 106 extending past the distal end of the first channel and plunger 124 is movable between the first position and the second position as plunger 124 moves along the longitudinal axis.
Patent NZ-501961-A (NZ)
Title: A therapy for improving cellular function in a heart challenged by insulin resistance, thereby protecting the heart from complications arising from this condition
Inventor: OLIN THOMAS
IPC: A61P3/08
Filed: 1998-06-26
Abstract: A therapy involving administration of human growth hormone for improving cellular function in the heart challenged by insulin resistance and thereby treating or protecting the heart from complications derivable from this condition is described.  Typically, the insulin resistance is induced by chronic stress or traumatic events including surgery, but it may also derive from conditions related to diabetes. The therapy is based on the finding that human growth hormone can exert insulin-like effects in cardiac cells and thereby is capable of replacing this hormone during insulin resistance.  In general, the therapy relates to the retention of an adequate glucose metabolism and resistance to stress in a heart challenged by insulin resistance, and the prevention of complications derived from the insulin resistance.
Patent NZ-504405-A (NZ)
Title: Method for killing bacteria or fungi comprising contacting them mammalian haemoglobin proteins and fragments thereof
Inventor: HOFFMAN BRIAN F
IPC: A01N63/50
Filed: 1998-08-10
Abstract: Compositions are provided, which are useful as antimicrobial agents.  The compositions comprise mammalian haemoglobin, the alpha and beta chains of haemoglobin free of haeme, fragments of the alpha and beta chains that result from cyanogen bromide cleavage of the alpha and beta chains, and synthetic peptides derived therefrom.  The compositions exert antimicrobial activity against both bacteria and fungi that is comparable to known antimicrobial peptides from human neutrophils, cathepsin G and azurocidin. Sensitive organisms include Gram-negative bacteria such as Escherichia coli and Pseudomonas aeruginosa, Gram-positive bacteria such as Staphylococcus aureus and Streptococcus faecalis, and the fungus Candida albicans.  Methods for preparing the compositions also are provided. Additionally, the compounds described can be used as disinfectant agents to sterilize or maintain microbe-free products.  Such products can include baby wipes, diapers, bandages, towelettes, make-up products, eyewash and contact lens solutions.  They may be administered to such products topically, in appropriate buffer or in liposome compositions. The antimicrobially effective amount to be administered will typically be in the range of from about 1500 ug to 50 mg/kg of treated material.
Patent NZ-505423-A (NZ)
Title: Wave-powered prime mover for use as a generator, turbine or reverse osmosis plant
Inventor: MURTAGH JOSEPH
IPC: B01D61/10
Filed: 1998-12-01
Abstract: A wave-powered prime mover comprises a pair of pontoons (2,  3)  connected  to a central inertial  barge  (1),  each pontoon  (2,  3) being pivotally movable by ocean  swell  or waves  relative  to  the barge (1).  A pump  (10)  connected between  each pontoon (2, 3) and the barge (1) converts  the motion  of  the  pontoon (2, 3) into water pressure  energy. An   improved  power  take-off  and  damping  mechanism   is provided for transforming incoming power, oscillating  at  a low  frequency, into a higher frequency oscillating form for use  in  a generator, turbine, reverse osmosis plant or  the like.  A hydraulic circuit (10, 32, 34, 35, 37, 39) is  used to  rectify  the incoming power into a uni-directional  form for  delivery as a continuous flow of pressurised water  for doing work such as that described above.
Patent NZ-509830-A (NZ)
Title: Drain with compartments to trap sediment and floating debris, and with rising float to indicate loading of debris
Inventor: BLACKET ARNOLD
IPC: E03F1/00
Filed: 2001-02-09
Abstract: A litter trap for a drain comprising an enclosure having a base, side walls, and a removable cover, a drain water inlet and exit above the base of the trap, the trap being divided by a weir into a first sediment collecting compartment and a second compartment that contains a sub-trap for collection of floating material, the two compartments facilitating high volume water transfer in extreme situations and being accessible form the removable top to facilitate collection of filtered media.
Patent NZ-509954-A (NZ)
Title: Folic acid and/or vitamin B12-lactoferrin complex
Inventor: UCHIDA TOSHIAKI
IPC: A23L33/15
Filed: 2001-02-15
Abstract: A folic acid and/or vitamin B12-lactoferrin complex, characterized in that the lactoferrin holds folic acid and/or vitamin B12. Also described are foods, drinks or medicines containing the complex described above.